Abstract
This review focuses on efforts toward target prioritization from several pathogenic bacteria applying integrated multi-omics approaches. In an integrative scheme, diverse layers of multi-omics data, genome-scale models (GSMs), and structural/functional data related to any pathogenic species can be used to prioritize genes and proteins with attractive target characteristics for the development of new antimicrobials agents. The reconstruction of genome-scale metabolic models (GSMMs) and transcriptional regulatory networks (TRNs) is described in detail. Also, we discuss the methods for the integration of GSMs and diverse web servers for drug targeting in pathogens. Structural approaches are also illustrated. We stress the clinical importance of the drug-resistant isolates related to severe nosocomial or community infections belonging to the species Klebsiella pneumoniae and Staphylococcus aureus, two of the six ESKAPE pathogens, as well as Mycobacterium tuberculosis, the causative agent of tuberculosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
